BioSpace News Archive

Dutch Ridge Consulting Group (DRCG), LLC, a Service-Disabled, Veteran-Owned Small Business (SDVOSB) headquartered in Beaver, PA, today announced that it has reached a distribution agreement for the Sienna™ COVID-19 IgG/IgM Rapid Test Cassette.

Progenabiome, a Ventura-based genetic sequencing research lab, welcomes two new advisory board members: Sheldon Jordan, MD, and Alexander Bystritsky, MD, PhD. Progenabiome is dedicated to understanding the clinical implications of the microbiome.

Promising overall survival outcomes at 3-years for high-risk, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) patients observed with Debio 1143 + CRT

INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced today that the European Patent Office (EPO) has granted EP Pat. No. 2,892,547,

At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (Nasdaq: MBOT), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System.

ValhallaMED, a manufacturer of MedTech devices designed to fight COVID-19, today announced the first-of-its-kind personal protective gear with air filtration and full face coverage — the NE-1 Helmet™

Vivera Pharmaceuticals, Inc. announced today the development of a new one-step testing cartridge for COVID-19 antibody testing. The ground-breaking cartridge will use a simplified procedure to help eliminate operator err

StageBio, a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for both preclinical and clinical research, has opened a new facility close to the biotechnology and medical research centers of Cambridge and Boston

AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with Ono Pharmaceutical Co., Ltd. (ONO) to manufacture new, innovative biopharmaceuticals at the clinical development stage. ONO is a R&D-oriented pharmaceutical company committed to discovering and developin

Aug. 13, 2020 13:00 UTC CAMBRIDGE, Mass.--( BUSINESS WIRE )-- E25Bio, rapid diagnostic innovators, announces award funding of $4.14M from the Bill & Melinda Gates Foundation and $1.68M from the NIH’s Small Business Innovation Research (SBIR) program. The pair of funding awards comes months after the startup announces funding from Khosla Ventures to develop and commercialize a rapid, inexpensive diagnostic for the COVID-19 pandemic. Launched in 2000, the Gates Foundation f